# Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A

> **NCT02282410** · NA · UNKNOWN · sponsor: **The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School** · enrollment: 15 (estimated)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** ADVATE

## Key facts

- **NCT ID:** NCT02282410
- **Lead sponsor:** The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02282410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02282410, "Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT02282410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*